Kampanjeplan NetraMark Holdings Inc.
Avansert tidsplan
Enkel graf
Om selskapet
NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. Its products suite comprises NetraAI, an interactive augmented intelligence platform; Netra Shatter; and Netra Health Atlas. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.
| Industry |
Health Care Technology |
| Sector |
Health Care |
| Валюта |
usd |
| Валюта отчета |
cad |
| Сайт |
https://www.netramark.com
|
| Цена ао |
0.1814 |
| Prisendring per dag: |
0% (0.716) |
| Prisendring per uke: |
+18.35% (0.605) |
| Prisendring per måned: |
+42.71% (0.5017) |
| Prisendring over 3 måneder: |
+294.71% (0.1814) |
| Prisendring over seks måneder: |
+232.87% (0.2151) |
| Prisendring per år: |
+186.74% (0.2497) |
| Prisendring over 3 år: |
0% (0.716) |
| Prisendring over 5 år: |
0% (0.716) |
| Prisendring over 10 år: |
0% (0.716) |
| Prisendring siden begynnelsen av året: |
0% (0.716) |
|
|
Undervurdering
| Navn |
Betydning |
Karakter |
| P/S |
0 |
0 |
| P/BV |
0 |
0 |
| P/E |
0 |
0 |
| EV/EBITDA |
0 |
0 |
| Total: |
|
2.5 |
|
Effektivitet
| Navn |
Betydning |
Karakter |
| ROA, % |
0 |
0 |
| ROE, % |
0 |
0 |
| Total: |
|
0 |
|
|
|
Utbytte
| Navn |
Betydning |
Karakter |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| Total: |
|
0 |
|
Plikt
| Navn |
Betydning |
Karakter |
| Debt/EBITDA |
0 |
10 |
| Total: |
|
10 |
|
Vekstimpuls
| Navn |
Betydning |
Karakter |
| Lønnsomhet Revenue, % |
-21.02 |
0 |
| Lønnsomhet Ebitda, % |
0 |
0 |
| Lønnsomhet EPS, % |
187.28 |
10 |
| Total: |
|
6 |
|
| Veileder |
Stillingstittel |
Betaling |
Fødselsår |
| Mr. George Achilleos |
CEO & Director |
|
|
| Mr. Josh Spiegel |
President |
|
|
| Mr. Daniel Gallucci |
Founder, Chief Performance Officer & Director |
|
1977 (48 år) |
| Dr. Joseph Geraci Ph.D. |
Founder, Chief Scientific & Technical Officer and Director |
|
|
| Mr. Swapan Kakumanu ACA, ACWA, CGA |
Chief Financial Officer |
|
1969 (56 år) |
| Ms. Jaime Hackett |
Vice President of Marketing |
|
|
| Dr. Luca Pani M.D. |
Chief Innovation & Regulatory Officer and Chief Medical Advisor |
|
|
| Dr. Kaveh Kavoosi |
Head of Progressive Medicine |
|
|
| Dr. Larry Alphs |
Chief Medical Officer & Member of Advisory Board |
|
|
| Mr. Mark Smithyes |
President of NetraMark |
|
1970 (55 år) |
